WHO: Genomic Studies Skewed Towards Rich Nations, LMICs Under 5%
A new WHO analysis reveals that less than 5% of disease-focused genomic studies are conducted in low and middle-income countries, while over 80% are concentrated in high-income nations. This significant disparity highlights major equity gaps in global health research. The report urges increased investment and more inclusive research in underserved regions.
- Under 5% of genomic studies originate from low, middle-income countries.
- Over 80% of genomic research is concentrated in high-income nations.
- India features among top 20 countries in genomic studies.
- Communicable diseases are severely underrepresented in studies.
- WHO calls for urgent global action to bridge research equity gaps.
- Report covers over 6,500 studies from 1990 to 2024.
Read the full story on Quick Digest.